Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|
peptide dosing

SYN-AKE Dosing & Reconstitution Guide

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Reviewed by Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Written by Volta Peptides Editorial Team · Reviewed September 15, 2026

June 17, 2026Updated September 11, 2026

This page serves as a reference for the synthetic peptide SYN-AKE, which is derived from the venom of the Temple Viper (Tropidolaemus wagleri). SYN-AKE is designed to mimic the effects of waglerin-1, a naturally occurring peptide that functions as a competitive antagonist at the nicotinic acetylcholine receptor (nAChR). Research has explored its potential in cosmetic applications, particularly for reducing the appearance of fine lines and wrinkles. The following sections detail the dosing parameters, supporting research, and safety considerations associated with SYN-AKE in a laboratory context.

About SYN-AKE

SYN-AKE is a synthetic tripeptide that mimics the action of waglerin-1, a peptide derived from Temple Viper venom. Its primary mechanism involves competitive antagonism at the muscular nicotinic acetylcholine receptor (nAChR), which leads to a decrease in muscle contraction frequency. This reduction in neuromuscular activity results in a relaxation of expression lines and a decrease in the depth of wrinkles, producing effects comparable to those of mild neurotoxins. The peptide's ability to modulate muscle contractions has garnered interest in cosmetic formulations aimed at wrinkle reduction, suggesting a novel approach to anti-aging treatments.

Dosing Protocol

The administration of SYN-AKE is typically conducted via topical application. Research indicates a frequency of 1 to 2 applications per day may be effective. In terms of concentration, serums containing SYN-AKE are generally formulated within a range of 1% to 4%. These parameters reflect findings from clinical studies that assess the efficacy of topical peptides in reducing the appearance of fine lines and wrinkles. It is important to note that these dosing parameters are derived from research studies and are not recommendations for personal use.

BPC-157 5mg
In Stock

BPC-157 5mg

5mg

Batch purity 99.9%· 10mg lot
$25 USD
5-Amino-1MQ 10mg
In Stock

5-Amino-1MQ 10mg

10mg

$34 USD
BPC-157 10mg
In Stock

BPC-157 10mg

10mg

Batch purity 99.9%
$35 USD

What the Research Shows

Research findings indicate that SYN-AKE has notable anti-wrinkle effects. A clinical study conducted by the manufacturer with a sample size of 45 participants revealed a 52% reduction in wrinkles after 28 days of treatment with SYN-AKE. Additionally, in vitro studies have confirmed the peptide's muscle relaxation properties, supporting its mechanism of action as a nAChR antagonist. While these results are promising, it is essential to consider the limitations of the study, including the relatively small sample size and the specific conditions under which the research was conducted, which may not fully represent broader populations.

Safety & Contraindications

SYN-AKE has been reported to be well-tolerated when applied topically, with minimal adverse effects noted in clinical evaluations. To date, no specific contraindications have been identified for its topical use. However, as with any cosmetic ingredient, it is crucial for researchers to conduct thorough assessments of individual responses, particularly in diverse populations. The safety profile of SYN-AKE underscores its potential as a candidate for cosmetic applications, although further research is warranted to establish long-term safety and efficacy.

Shop Research Peptides

BPC-157 5mg
In Stock

BPC-157 5mg

5mg

Batch purity 99.9%· 10mg lot
$25 USD
5-Amino-1MQ 10mg
In Stock

5-Amino-1MQ 10mg

10mg

$34 USD
BPC-157 10mg
In Stock

BPC-157 10mg

10mg

Batch purity 99.9%
$35 USD
GHK-Cu 100mg
In Stock

GHK-Cu 100mg

100mg

$39 USD
GHK-Cu 50mg
In Stock

GHK-Cu 50mg

50mg

$25 USD
Ipamorelin 5mg
In Stock

Ipamorelin 5mg

5mg

$28 USD
KPV 10mg
In Stock

KPV 10mg

10mg

$30 USD
Melanotan II 10mg
In Stock

Melanotan II 10mg

10mg

$28 USD
MOTS-C 10mg
In Stock

MOTS-C 10mg

10mg

$28 USD

Quality Documentation

Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.

Product cards on this page link to current catalog entries and available quality documentation.

Frequently Asked Questions

Related Research

About the reviewer

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.

Marcus reviewed this article for scientific and analytical accuracy on September 15, 2026. He did not write it. Technical review is internal review and is not peer review, independent third-party review or medical review.

Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.